Announced Fri, 19 Jun · 15:13 IST
PAC buys 2.49 lakh shares of Parmax Pharma during open offer period
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹68.02
prior close
₹69.38
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0—+4.0+6.1+8.2+10.4+12.6+17.1+37.2+51.3——
Up moveDown movePending
AI summary
Abhay Chinubhai Shah (PAC 8) bought 2,49,394 equity shares of Parmax Pharma at Rs. 35 each via off-market deal on June 18, 2026, from Pradeep, Vandana, and Nimit Gosalia. His stake rose from nil to 2.76 percent. Combined acquirer and PAC shareholding increased from 20.54 percent to 27.20 percent. Disclosure filed under SEBI SAST Regulation 18(6) during the ongoing open offer, with public announcement dated June 8, 2026 and detailed public statement on June 15, 2026.
Likely market impact
Acquirer and PAC group stake in Parmax Pharma climbs to 27.20 percent as PAC 8 adds shares at Rs. 35 each during the open offer period.